These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16273221)

  • 1. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
    Wu J; Liang Y; Nawaz Z; Hyder SM
    Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells.
    Garofalo C; Sisci D; Surmacz E
    Clin Cancer Res; 2004 Oct; 10(19):6466-75. PubMed ID: 15475434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.
    Hyder SM; Stancel GM
    Cancer Lett; 2002 Jul; 181(1):47-53. PubMed ID: 12430178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
    Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM; Rowan BG
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
    Ku TK; Crowe DL
    J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone signaling in breast and endometrium.
    Ballaré C; Vallejo G; Vicent GP; Saragüeta P; Beato M
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):2-10. PubMed ID: 17070033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.